Value of inflammatory index in blood routine on the prognosis of hepatocellular carcinoma
10.3760/cma.j.issn.1673-4203.2020.03.013
- VernacularTitle:血常规中炎症指标对肝细胞肝癌预后的价值
- Author:
Yifeng WU
1
;
Chaoyong TU
;
Chuxiao SHAO
Author Information
1. 温州医科大学附属第一医院肝胆胰外科 325000
- From:
International Journal of Surgery
2020;47(3):206-211
- CountryChina
- Language:Chinese
-
Abstract:
Chronic inflammation and tumor occurrence and development, recurrence and metastasis and immune escape and other key links have a far-reaching impact. The level of inflammation and immunity can be reflected by the markers of inflammatory response, including C-reactive protein, neutrophils, platelets, lymphocytes and their combinations in the blood, such as neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, lymphocyte to monocyte ratio, systemic immune inflammation index and so on. At present, inflammatory index has been proved to be predictors of recurrence and survival in a variety of malignant tumors. Hepatocellular carcinoma (HCC), as a common invasive tumor, is often diagnosed in the late course of the disease, so patients often can not achieve a satisfactory prognosis. This article mainly reviews the clinical application of the above inflammatory response indexes in HCC.
